The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases

E Possemato, L La Barbera, A Nobili, P Krashia… - Ageing research …, 2023 - Elsevier
Abstract In the Central Nervous System (CNS), neuroinflammation orchestrated by microglia
and astrocytes is an innate immune response to counteract stressful and dangerous insults …

Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer's disease: Current trends and future perspectives

L La Barbera, E Mauri, M D'Amelio… - Frontiers in neuroscience, 2022 - frontiersin.org
Alzheimer's disease (AD), the most common form of dementia, is a progressive and
multifactorial neurodegenerative disorder whose primary causes are mostly unknown. Due …

Upregulation of Ca2+-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer's disease in Tg2576 mice

L La Barbera, A Nobili, E Cauzzi, I Paoletti… - Molecular …, 2022 - Springer
Background Recent clinical and experimental studies have highlighted the involvement of
Ventral Tegmental Area (VTA) dopamine (DA) neurons for the early pathogenesis of …

[HTML][HTML] Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer's Disease

L La Barbera, F Vedele, A Nobili, P Krashia… - Progress in …, 2021 - Elsevier
What happens precociously to the brain destined to develop Alzheimer's Disease (AD) still
remains to be elucidated and this is one reason why effective AD treatments are missing …

Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer's Disease

E Spoleti, L La Barbera, E Cauzzi, ML De Paolis… - Molecular …, 2024 - nature.com
Early and progressive dysfunctions of the dopaminergic system from the Ventral Tegmental
Area (VTA) have been described in Alzheimer's Disease (AD). During the long pre …

Explainable deep-learning-based diagnosis of Alzheimer's disease using multimodal input fusion of PET and MRI Images

M Odusami, R Maskeliūnas, R Damaševičius… - Journal of Medical and …, 2023 - Springer
Purpose Alzheimer's disease (AD) is a progressive, incurable human brain illness that
impairs reasoning and retention as well as recall. Detecting AD in its preliminary stages …

In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer's disease phases

A Sala, SP Caminiti, L Presotto, A Pilotto… - Alzheimer's Research & …, 2021 - Springer
Background Preclinical and pathology evidence suggests an involvement of brain dopamine
(DA) circuitry in Alzheimer's disease (AD). We in vivo investigated if, when, and in which …

Comparative metagenomics and metabolomes reveals abnormal metabolism activity is associated with gut microbiota in Alzheimer's disease mice

P Sun, H Zhu, X Li, W Shi, Y Guo, X Du… - International Journal of …, 2022 - mdpi.com
A common symptom in Alzheimer's disease (AD) is cognitive decline, of which the potential
pathogenesis remains unclear. In order to understand the mechanism of gut microbiota in …

The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease

P Krashia, E Spoleti, M D'Amelio - Frontiers in Psychiatry, 2022 - frontiersin.org
Neuropsychiatric symptoms (NPS) occur in nearly all patients with Alzheimer's Disease
(AD). Most frequently they appear since the mild cognitive impairment (MCI) stage preceding …

Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model

E Spoleti, P Krashia, L La Barbera, A Nobili… - Experimental …, 2022 - Elsevier
Gradual decline in cognitive and non-cognitive functions are considered clinical hallmarks of
Alzheimer's Disease (AD). Post-mortem autoptic analysis shows the presence of amyloid β …